Pfizer Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Pfizer Ltd. from all sources in a single place.

09 Oct 2025

5321.50

-0.25%

Pfizer-Trump deal: What it means for drug prices and pharma giants in US

Business Standard

Pfizer has pledged to make some medicines available at lower prices for the Medicaid programme and in return gained relief from immediate import tariffs

Number of FII/FPI investors increased from 129 to 139 in Jun 2025 qtr.

Pfizer Ltd.

08 Oct 2025

5321.50

-0.25%

Company Update

Pfizer Ltd - 500680 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2025.

pdf

Pfizer Ltd.

03 Oct 2025

5321.50

-0.25%

Pfizer's drug-price deal with Trump follows months of negotiation deadlock

Business Standard

Pfizer and the White House were deadlocked for months over lowering US drug prices, with Trump demanding quick results from drug executives right from the start of his second term

Pfizer Ltd. has gained 26.65% in the last 6 Months

Pfizer Ltd.

01 Oct 2025

5321.50

-0.25%

TrumpRx, Medicaid discounts and most-favoured-nation pricing: What Pfizer's agreement means

Business Line

President Donald Trump announced a deal with Pfizer to lower US drug costs by cutting Medicaid prices and aligning new drug prices with other high-income countries. The agreement also includes Pfizer onshoring all imported pharmaceuticals to avoid US tariffs.

Pfizer Ltd. has gained 26.65% in the last 6 Months

Pfizer strikes drug pricing deal with Trump administration, invests $70 bn in US

Business Line | 01 Oct 2025 2 more

Pfizer Ltd.

01 Oct 2025

5321.50

-0.25%

Pfizer to lower prescription drug costs for Medicaid in deal with Trump

Business Standard

Drugmaker Pfizer has agreed to lower drug costs under a deal struck with the Trump administration, President Donald Trump said Tuesday, as he promised similar deals will be struck with other drugmakers facing a threat of tariffs. The announcement, which Trump made with Pfizer CEO Albert Bourla at the White House, came as the Republican president has for months sought to lower drug costs. It also came as Washington faced a federal government shutdown at midnight amid a standoff between Democrats and Republicans over health care and its costs. Under the agreement, New York-based Pfizer will charge most-favoured-nation pricing to Medicaid and guarantee that pricing on newly launched drugs, Trump said. That involves matching the lowest price offered in other developed nations. I can't tell you how big this is," the president said. I think," Bourla said, today we are turning the tide and we are reversing an unfair situation. Trump has been talking for months about the need to lower dru